Not Rated
|
Fund Size
(0.12% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 10-Nov-25 | 10083.00 | 0.83% | - | 1.30% | 191/242 |
| 1 Month | 17-Oct-25 | 9873.90 | -1.26% | - | 1.15% | 222/235 |
| 3 Month | 14-Aug-25 | 9820.90 | -1.79% | - | 4.98% | 234/235 |
| Since Inception | 27-Jun-25 | 9672.40 | -3.28% | -8.15% | 12.97% | 210/216 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 574.8 | 9.25% | -1.39% | 12.51% (Aug 2025) | 0% (Nov 2024) | 3.40 L | -0.70 L |
| Mankind Pharma Ltd. | Pharmaceuticals | 453 | 7.29% | -0.24% | 7.53% (Sep 2025) | 0% (Nov 2024) | 1.90 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 438.1 | 7.05% | -0.59% | 7.64% (Sep 2025) | 0% (Nov 2024) | 65.03 k | -0.17 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 384.1 | 6.18% | 0.15% | 6.18% (Oct 2025) | 0% (Nov 2024) | 50.00 k | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 344.3 | 5.54% | 0.10% | 5.54% (Oct 2025) | 0% (Nov 2024) | 3.00 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 334 | 5.38% | -0.06% | 5.55% (Aug 2025) | 0% (Nov 2024) | 2.23 L | 0.00 |
| Aster DM Healthcare Ltd. | Hospital | 305.1 | 4.91% | 0.83% | 4.91% (Oct 2025) | 0% (Nov 2024) | 4.50 L | 50.00 k |
| Abbott India Ltd. | Pharmaceuticals | 284.2 | 4.57% | 0.28% | 4.57% (Oct 2025) | 0% (Nov 2024) | 9.80 k | 800.00 |
| AstraZeneca Pharma India Ltd. | Pharmaceuticals | 248.4 | 4.00% | 0.67% | 4% (Oct 2025) | 0% (Nov 2024) | 26.00 k | 3.50 k |
| Gland Pharma Ltd. | Pharmaceuticals | 231.5 | 3.73% | 0.81% | 3.73% (Oct 2025) | 0% (Nov 2024) | 1.20 L | 30.00 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 4.73% |
| Net Receivables | Net Receivables | -0.26% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 2.63 | 14.49 | 44.68 | 43.35 | 35.14 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 0.96 | 2.61 | 14.67 | 29.19 | 15.26 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 4.45 | 9.70 | 18.68 | 25.31 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 1.68 | 8.32 | 17.37 | 23.55 | 12.64 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.77 | 10.08 | 18.60 | 23.12 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.94 | 7.33 | 11.43 | 22.25 | 19.79 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.67 | 9.12 | 8.59 | 21.83 | 13.64 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | 2.20 | 3.48 | 12.80 | 21.73 | 16.54 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.47 | 8.13 | 7.34 | 21.59 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.16 | 7.83 | 9.06 | 20.57 | 17.54 |
Out of 54 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 3 is/are ranked 4 * , 8 is/are ranked 3 * , 4 is/are ranked 2 * , 3 is/are ranked 1 * , and 35 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Baroda BNP Paribas Liquid Fund - Regular Plan - Growth | 3 | 9502.33 | 0.48 | 1.42 | 2.93 | 6.55 | 6.93 |
| Baroda BNP Paribas Balanced Advantage Fund - Growth | NA | 4544.91 | 1.95 | 5.12 | 6.20 | 10.18 | 14.27 |
| Baroda BNP Paribas Balanced Advantage Fund - Growth | NA | 4544.91 | 1.95 | 5.12 | 6.20 | 10.18 | 14.27 |
| Baroda BNP Paribas Money Market Fund - Growth | 3 | 4335.34 | 0.51 | 1.58 | 3.32 | 7.47 | 7.22 |
| Baroda BNP Paribas Multi Cap Fund - Regular Plan - Growth | 3 | 3108.17 | 0.88 | 4.52 | 5.52 | 4.36 | 19.07 |
| Baroda BNP Paribas Large Cap Fund - Regular Plan - Growth | 3 | 2729.20 | 1.30 | 4.05 | 3.28 | 5.57 | 15.40 |
| Baroda BNP Paribas Mid Cap Fund - Regular Plan - Growth | 3 | 2276.13 | 3.62 | 6.87 | 7.86 | 8.30 | 20.74 |
| Baroda BNP Paribas Large and Mid Cap Fund - Regular Plan - Growth | 2 | 1697.43 | 1.90 | 5.47 | 5.31 | 4.65 | 18.49 |
| Baroda BNP Paribas India Consumption Fund - Growth | NA | 1552.24 | -1.29 | 4.30 | 4.11 | 5.64 | 16.49 |
| Baroda BNP Paribas Gilt Fund - Regular Plan - Growth | 5 | 1341.67 | -0.53 | 0.26 | -0.62 | 6.22 | 7.54 |